Pfizer admits takeover of AstraZeneca would lead to cuts in UK jobs and R&D

Pfizer boss Ian Reed’s admission to MPs follows his repeated reassurances proposed deal would be a ‘win-win’ for UK

MPs grill pharma bosses on takeover

US drug firm Pfizer has admitted that its proposed £63bn takeover of UK rival AstraZeneca would lead to job cuts and a big reduction in the combined companies’ research and development spending.

Pfizer’s chief executive, Ian Read, who was subjected to a sustained questioning by MPs on Tuesday, admitted that despite his repeated assurances that the takeover would be "win-win" for the UK "there will be some job cuts".

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us